Myung In Pharmaceutical LTD. (KRX:317450)

South Korea · Delayed Price · Currency is KRW

56,900

+600 (1.07%)

At close: Apr 8, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Pharmaceutical			239.42B	223.25B	207.85B	187.84B	180.14B
Pharmaceutical Growth			7.24%	7.41%	10.65%	4.27%	6.61%
Real Estate Rental			3.08B	2.77B	1.60B	33.67M	1.64B
Real Estate Rental Growth			11.01%	73.00%	4661.04%	-97.95%	6.38%
Advertising Agency			3.30B	2.66B	3.37B	3.53B	2.60B
Advertising Agency Growth			24.04%	-21.05%	-4.67%	35.84%	-
Consolidation Adjustment			-3.46B	-2.85B	-3.57B	-3.57B	-2.60B
Total			242.34B	225.83B	209.25B	187.84B	181.79B
Total Growth			7.31%	7.92%	11.40%	3.33%	6.61%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
South Korea			242.34B	225.83B	209.25B	187.84B	181.79B
South Korea Growth			7.31%	7.92%	11.40%	3.33%	6.61%
Total			242.34B	225.83B	209.25B	187.84B	181.79B
Total Growth			7.31%	7.92%	11.40%	3.33%	6.61%

Source: S&P Global Market Intelligence.